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With over a billion people infected worldwide, neglected tropical diseases (NTDs) are 
so named not just because of inadequate research and resources but also because of the 
populations they infect. These are often the poorest of the poor, living on less than US$2 a 
day. NTDs cripple the poor through social and economic oppression, creating a vicious cycle 
of neglect. As a particularly vulnerable population, women (both as a sex and as a gender) 
have distinct challenges. While these diseases have a physical impact on a woman’s body, 
their roles and expectations within a society can further exacerbate the burden of NTDs. With 
proposals focused on human rights and the Millennium Development Goals, the cycle of 
neglect can be broken through empowering women medically, politically, economically, and 
socially. This project presents an analysis of the literature regarding the relationship of 
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Globally, one billion people are infected with neglected tropical diseases (NTDs), 
killing approximately 534,000 people every year (Médecins Sans Frontières [MSF], 2012). 
Mortality rates alone do not reflect the true burden of these diseases. Increased risk of 
HIV/AIDS, blindness, stigma, and deformities has devastating effects, perpetuating a cycle 
of neglect (Rilkoff, Tukahebwa, Fleming, Leslie, & Cole, 2013). Composed of a variety of 
pathogens including bacteria, viruses, protozoa, and helminthes, these diseases are so named 
not just because of inadequate research and resources but also because of the population they 
infect, often the poorest of the poor, living on less than US$2 a day (Hotez & Kamath, 2009). 
While this degree of poverty can certainly exist in the city, this population is more commonly 
found in the rural areas that have inadequate resources. Neglected tropical diseases (NTDs) 
act as a clear demarcation between the rich and the poor, disproportionately affecting those in 
poverty and suggesting a deeper injustice rooted in structural violence. These diseases 
physically, politically, economically, and socially cripple the poor.1 
As a sub-set of this vulnerable population, women—both as a sex and as a 
gender—have distinct challenges in the face of NTDs. While sex is a biological determinant, 
gender is a social construct that develops and evolves over time (Vlassoff & Moreno, 2002). 
Some of these diseases have particular biological relevance to the sex of women. For 
example, lymphatic filariasis is often manifested in the breast or vulva of women (Hotez, 
2009), and certain drugs are unsafe when women are pregnant or breastfeeding (Rilkoff et 
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al., 2013). In addition to the biological factors, the roles and expectations of women in 
society can compound their health outcomes, much like social class (Vlassoff & Moreno, 
2002). Women may be expected to suffer in silence (Vlassoff & Moreno, 2002), to purchase 
bed nets for their entire household (Clemmons et al., 2009), or to merely bear children 
(World Health Organization Regional Office for Africa [WHO Africa], 2012). With these 
vulnerabilities in mind, medical interventions can take a more defined and targeted approach. 
To prevent overgeneralizations among patients, understanding the risks and impacts of sex 
and gender on diseases is an important first step in providing quality healthcare. 
In terms of disease intervention, programs must pass through different stages. 
Molyneux (2006) describes this process. Initially, the goal is control, or simply reducing the 
rate of transmission and incidences of infection. After the incidences of infection are reduced 
to zero in certain regions, the disease is considered eliminated in that region, but it may still 
require certain intervention strategies to prevent new infections. The ultimate goal of most 
NTD programs is eradication, or reducing worldwide infection to zero so that intervention 
strategies are no longer needed (Molyneux, 2006).  
While mass drug administration and community medicine distributors are the primary 
strategies to control NTDs, inadequate training, inconsistent delivery, and community 
protests pose problems (Rilkoff et al., 2013). Furthermore, since NTDs seem to stem from 
social and economic disparities, solutions must extend beyond the biomedical approach. 
Empowering women (Hotez, 2009), targeting equality through health policies (Gazzinelli, 
Correa-Oliveira, Yang, Boatin, & Kloos, 2012), improving technology and infrastructure 




forming coalitions with water, sanitation and hygiene programs (Freeman et al., 2013) 
provide promising, comprehensive solutions. 
Though the control and eradication of NTDs is a complex problem, it is not a problem 
that can be ignored. According to Articles 25 and 27 in the United Nations Universal 
Declaration of Human Rights (1948), everyone has the right to adequate healthcare and the 
right to share in scientific advancement, respectively. Furthermore, the control and 
eradication of NTDs can contribute to the achievement of the Millennium Development 
Goals (MDGs), which the United Nations established in 2002 to end poverty by 2015. Some 
of these goals include combating “other diseases,” improving maternal health, promoting 
gender equality, and empowering women. As men and women have different social 
determinants of health, solutions for effectively eradicating neglected tropical diseases in 
Sub-Saharan Africa depend on a clear understanding and evaluation of the risks and impact 





CYCLE OF NEGLECT: POVERTY AND DISEASE 
 
Appropriately, neglected tropical diseases (NTDs) are considered “neglected” for two 
major reasons: (1) the majority of the population affected are vulnerable populations living in 
conditions of poverty, and (2) research and development initiatives are relatively 
underfunded and underdeveloped compared to more popular diseases. This creates a vicious 
cycle of neglect. NTDs act as oppressive forces that prevent individuals from obtaining 
higher social or economic statuses, constraining them to the conditions of poverty. 
Meanwhile, the social and economic elements of poverty create a feedback loop that allows 
NTDs to thrive. 
As poverty is the leading cause of mortality and suffering, efforts in eradicating 
NTDs must also contribute to the eradication of poverty. While eradicating NTDs may 
relieve suffering, it does not treat the underlying root problem. It is like treating a brain tumor 
with Advil: it might relieve the headache for a short time but it does nothing to cure the 
cancer in the long run. A new NTD will always metastasize. When someone dies from a 
preventable and treatable disease, like many of these NTDs, it is more than social injustice. 
As these deaths are concentrated within the lowest socioeconomic group, then something 
must be said of the larger context and system that is allowing these persistent injustices to 
occur. This larger oppressive force is known as structural violence. 
Vulnerable Populations 
The word ‘poverty’ contains many different definitions, some of which are more 




to try to standardize the definition. A relative poverty line, such as using a percentage of the 
national median income, can vary from place to place and time to time, creating challenges 
when trying to analyze the evolution of poverty. The data is hardly standardized. As such, the 
World Bank uses an absolute poverty line, which is only adjusted for inflation, to allow for 
better tracking of poverty (Haughton & Khandker, 2009). When one is below the income 
level required to meet the daily needs of living, such as food, water, and shelter, then one is 
considered to be in poverty (Vidyasagar, 2006).  
The World Health Organization (WHO) draws this line at the cost required to 
purchase 2200 calories per day per person (Vidyasagar, 2006). In the past, the World Bank 
has used two different absolute poverty levels: US$2 per day and US$1.25 per day. Using 
these estimates, 73% of the population (556.7 million people) in Sub-Saharan Africa (SSA) 
lives on less than US$2 per day, and 51% (390.6 million people) lives on less than US$1.25 
per day (Hotez & Kamath, 2009). However, it is hard to draw meaning from daily income or 
the cost of calories. These numbers are only numbers; they do not reflect the true condition 
of poverty. 
Economic deprivation only represents a portion of the definition of poverty. The 
United Nations defined poverty much more broadly. In May 1998, the Administrative 
Committee on Coordination (ACC) issued the following as part of a “Statement of 
Commitment for Action to Eradicate Poverty”: 
ACC emphasizes that fundamentally, poverty is a denial of choices and opportunities, 
it is a violation of human dignity. It means lack of basic capacity to participate 
effectively in society. It means not having enough to feed and clothe a family, not 
having a school or a clinic to go to, not having the land on which to grow one's food 
or a job to earn one's living, nor having access to credit. It means insecurity, 
powerlessness and exclusion of individuals, households and communities. It means 




environments, not having access to clean water and sanitation (Administrative 
Committee on Coordination [ACC], 1998). 
The ACC is now known as the Chief Executives Board for Coordination, and it acts as the 
principal coordinator for the United Nations with executive heads representing every UN 
agency, organization, and fund. While this definition does contain connotations of one’s 
economic status, the language also indicates a certain amount of social oppression. In fact, it 
can be argued that up to 13 components of poverty are contained in this definition alone. 
However, definitions of words like “choice,” “dignity,” “powerlessness,” and “exclusion” 
remain almost impossible to operationalize.  
Whether social or economic, all of these components are intricately intertwined with 
neglected tropical diseases (NTDs). In fact, many of the conditions that define poverty are 
the same conditions that place individuals at particular risk for contracting NTDs, such as 
unclean water, poor hygiene, inadequate housing, lack of nutrition, and weak immune 
systems (Gazzinelli et al., 2012). Of the one billion people who are infected by NTDs, 
poverty is the common link between all of these infections, acting as a sort of co-requisite for 
the existence of NTDs (Bergquist & Whittaker, 2012). Colloquially, the population that is 
infected by these diseases is referred to as the “bottom billion.” 
The bottom billion is at risk for more than just death. An unhealthy physical body can 
lead to an unhealthy social body. For example, hookworm infection and schistosomiasis, two 
common NTDs, have been known to cause anemia, which can decrease productivity, impair 
growth, and delay cognitive development (Bergquist & Whittaker, 2012). Accordingly, the 
WHO and scholarly journals reference the disability-adjusted life year (DALY), which is a 




equivalent to the loss of one year of healthy life, which can be due to either disability or 
premature death (WHO, 2014a). For example, if the life expectancy of a woman in a specific 
country is 60 years, and she develops blinding trachoma at age 40 and dies at age 50, then a 
total of 20 DALYs are lost: ten because of disability and ten because of premature death. 
In Sub-Saharan Africa, 8.6 to 21.2 million DALYs are lost annually due to NTDs 
(Hotez & Kamath, 2009). Using data from the WHO’s Global Health Observatory Data 
Repository (2013), Africa lost almost 13.5 times as many DALYs as North and South 
America combined and over 1,000 times as many DALYs as Europe due to “tropical 
diseases” in 2004. It is important to note that this category does not include all NTDs, as 
diseases such as trachoma and hookworm have their own category. Figure 1 represents the 
data a bit differently by examining the data by the level of income as opposed to 
geographical relevance. The low income group appears to carry a significantly heavier 
burden of the diseases. The relationship between income level and infection is obvious. 
While it would be easy to assume that poverty is the cause of NTDs, the relationship 























FIGURE 1: Trend of DALYs Lost Due to "Tropical 












poverty, like poor sanitation and lack of clean drinking water, which caused the disease? Or 
was it the symptoms of the disease, such as blindness or cognitive impairment, which 
inhibited people from thriving and forced them into poverty? In this sense, NTDs and 
poverty are best understood as correlational, not causal. While a lower income may 
contribute to a greater rate of NTD infection, it is just as likely that a greater rate of NTD 
infection may contribute to a lower income.  
Figure 2 best simplifies the complexity of poverty and neglected tropical diseases, as 
both seem to be defined and connected by social and/or economic oppression. The cycle of 
neglect is similar to that of a circle; it has no beginning or end. Individuals may enter into 
this cycle at any point and then continue in any direction. Accordingly, individuals should be 
able to exit the cycle at any point. Trying to funnel one billion people out of a single exit 
FIGURE 2: Cycle of Neglect 
This figure demonstrates that both social and economic oppression contribute equally 




would take too much time, and too many people would die trying to get to the front of the 
line. Elimination of poverty and NTDs therefore require not just a break in the cycle but a 
complete shattering of it, allowing for exits at any point. 
Women are especially at risk of entering into this cycle. The ACC (1998) identifies 
women as a particularly vulnerable population that are often the main victims of poverty. 
Bergquist and Whittaker (2012) also emphasize gender bias as a risk factor for NTDs. 
Finally, Peter Hotez (2009), Co-Editor-in-Chief of the Public Library of Science Neglected 
Tropical Diseases journal and Dean of the National School of Tropical Medicine at Baylor 
College of Medicine, highlights the need and urgency for social science research in regards 
to gender inequalities and NTDs. Thus, this research will specifically analyze the risk factors 
and impacts of this cycle of neglect on women. 
Underfunded and Underdeveloped 
The other component of neglect in defining these diseases deals with how they are 
managed. Adopting a clinical analogy, their management can be broken down into four 
different levels: diagnosis, prognosis, treatment, and delivery. The diagnosis level mainly 
deals with trying to name and define NTDs, while the prognosis level focuses on research of 
a disease’s progression. Treatment is largely based on pharmaceutical companies’ production 
of medications. Delivery can take multiple approaches, but it largely exists as mass drug 
administration. All four of these levels are underfunded and underdeveloped. 
At the diagnosis, or definition level, the diseases that are considered “neglected” vary 
from organization to organization. As seen in Table 1, a total of 55 diseases are identified 
across the selected organizations, though not all of these diseases are endemic to Sub-





TABLE 1: Diseases Identified as "Neglected" Sorted by Organization 









































Amebiasis               
Balantidiasis               
Bartonella               
Bovine Tuberculosis in Humans               
Buruli Ulcer (Mycobacterium ulcerans)               
Chagas disease (American trypanosomiasis)               
Cholera               
Chronic suppurative otitis media (CSOM)        
Dengue               
Dracunculiasis (guinea-worm)               
Echinococcosis               
Enteric pathogens (Shigella, Salmonella, E. coli)               
Foodborne trematodiasis               
Giardiasis               
Human African Trypanosomiasis (sleeping sickness)               
Human Papillomavirus (HPV)               
Japanese encephalitis               
Jungle yellow fever               
Leishmaniasis               
       cutaneous leishmaniasis               
       mucocutaneous leishmaniasis               
       visceral leishmaniasis (kala-azar or black fever)               
Leprosy               
Leptospirosis               
Loiasis               
Lymphatic Filariasis (elephantiasis)               
Mycetoma               
Myiasis               
Nodding Syndrome (NS)        













































Other arboviral infections        
Paracoccidiomycosis        
Podoconiosis               
Rabies               
Relapsing Fever               
Rift Valley fever               
Scabies               
Schistosomiasis               
Snakebite               
Taeniasis-Cysticercosis (tapeworm)               
Toxocariasis and other Larva Migrans               
Trachoma               
Treponematoses               
Bejel               
       Pinta               
       Syphilis               
       Yaws               
Soil-transmitted helminths               
       Ascarisasis               
       Hookworm               
       Roundworm               
       Strongyloidiasis               
       Trichuriasis               
       Whipworm               
Viral Hemorrhagic fevers               
        
  Positively Identified 
  Other Neglected 
  Transition Diseases 
                                                        Legend: 
  Newly Identified 




range of perspectives: Public Library of Science Neglected Tropical Diseases (PLoS NTD) is 
an academic journal; World Health Organization (WHO) is an international health agency; 
the London Declaration is an agreement between many pharmaceutical companies; the Gates 
Foundation is a general grant-providing agency for research and development; United States 
Agency for International Development Neglected Tropical Diseases Program (USAID) is a 
domestic program that provides aid to developing regions; Drugs for Neglected Diseases 
Initiative (DNDi) is a non-profit agency that focuses on policy-making and research and 
development; and Médecins Sans Frontières (MSF) is an international medical agency.  
 With so many stakeholders, it becomes difficult to consistently define which diseases 
can actually be classified as “neglected.” In some cases, overlap and agreement exist. In 
others, gaps exist.  In fact, not one single disease is identified across all seven organizations. 
Furthermore, some agencies have separated their NTDs into different categories based on 
funding or some other unknown characteristic. Diseases that are identified as “transitional” 
by the Gates Foundation are soon no longer going to receive funding, while “new” diseases 
will receive new or increased funding (Bill & Melinda Gates Foundation, n.d.). Meanwhile, 
WHO gives no explanation as to why seven conditions are separated into a distinct “other” 
category. 
Malaria, tuberculosis, and HIV, sometimes referred to as the “Big Three” of 
mortality-causing diseases, generally receive more resources and commercial support for  
research and development (R&D) than the “most neglected” diseases discussed here, which 
receive little to no resources and R&D activity (Drugs for Neglected Diseases Initiative & 
Médecins Sans Frontières [DNDi & MSF], 2012). In 2008, 72.8% of the global funding went 




terms of DALYs, the total disease burden of NTDs in Africa has been estimated to be twice 
that of tuberculosis and half that of malaria (Hotez & Kamath, 2009). While the Big Three 
are explicitly mentioned in the Millennium Development Goals (MDG), NTDs are still 
brushed aside in a general, nondescript category called “other diseases” (Gazzinelli et al., 
2012). As such, the Big Three are excluded from much of the literature describing NTDs and 
intentionally omitted from the scope of this study.  
Of the most common 17 NTDs identified by the WHO, the Centers for Disease 
Control and Prevention (CDC, 2011) recognizes six as “tool-ready,” meaning that from 
detection to treatment, every level necessary to effectively complete mass drug 
administration (MDA) has been developed. The remaining eleven NTDs are considered 
“tool-deficient,” which means at least one of these levels is not fully developed. The 
USAID’s NTD Program focuses on these tool-ready diseases (CDC, 2011) and emphasizes 
the importance of controlling these diseases through an integrated approach because of the 
geological overlap for co-infections (USAID, 2012). However, a limited focus on only six 
diseases hardly seems integrated. Meanwhile, MSF has taken the opposite approach, 
claiming that tool-deficiency should not and cannot stop quality care from being delivered to 
patients infected by one of these diseases (MSF, 2012). Unfortunately, MSF only recognizes 
four NTDs, a small fraction of all the identified diseases.  
Whether tool-ready or tool-deficient, funding for NTDs is often mismanaged and 
insufficient (Moran, 2011). While the United States’ pledge to increase their current NTD 
program to combat and eradicate 10 NTDs by the end of the decade is commendable 
(Uniting to Combat Neglected Tropical Diseases, 2012), the budgetary funds in 2013 were 




2014-2015, tropical disease research was reduced by more than 52% compared to the 2012-
2013 budget. Research that is being conducted and funded is often not a reflection of actual 
need and tends to focus on basic research that is unlikely to yield any practical treatments for 
patients (Moran, 2011). While research that is aimed at deepening the understanding of the 
prognosis of these diseases can certainly lead to practical outcomes, research dedicated to 
product development and treatment plans are arguably more effective. 
At the treatment level, pharmaceutical companies have also underinvested in the 
battle with NTDs. Between 1975 and 2004, of the 1556 new drugs developed, only 10 treated 
neglected tropical diseases (MSF, 2012). As pharmaceutical drugs exist in a market-driven 
economy, these companies often develop products that will guarantee them a large return on 
investment (Moran, 2011). Furthermore, these products are often developed with the intent of 
being delivered in resource-rich conditions, which is hardly effective in developing countries 
(DNDi & MSF, 2012). However, in the case of NTDs, the target population cannot afford 
expensive medications or complicated treatment plans. As a result, pharmaceutical 
companies have little incentive to increase investments in research and development for a 
market that cannot pay. When the profit-driven market controls essential medical 
interventions, only the rich stand to benefit, leaving the poor neglected and sick (Pérez-
Casas, Herranz, & Ford, 2001). Instead, pharmaceutical companies have taken a different 
route: donations. Some companies, such as Pfizer, Sanofi, and Novartis, have made 
commitments to donate unlimited quantities of drugs for select diseases, namely human 
African trypanosomiasis, lymphatic filariasis, onchocerciasis, and leprosy (World Health 
Organization Department of Control of Neglected Tropical Diseases [WHO NTD], 2013). 




component of current strategies to control NTDs is through the delivery of these drugs, 
known as mass drug administration (MDA). Community medicine distributors (CMDs) play 
a key role in MDA. CMDs are trained community members who distribute medicines and 
educate other members of the community on disease through either a door-to-door approach 
or through a centralized location (Rilkoff et al., 2013). As an example of the scale of MDA, 
every year since 2012, approximately 700 million children received preventative medicine 
for trachoma and helminthiases (WHO NTD, 2013). While this is certainly a large portion of 
the population, the number only represents two of the diseases. Other diseases are also 
treated by MDA, and often, one drug can prevent multiple diseases, indicating a heavy 
reliance on a particular chemical compound. 
Conventional MDA may look good on paper because of its ability to deliver large 
amounts of preventative medicine to a vast amount of people at once, but they are also a 
cause for concern. While a fairly cost-effective method, it often relies on unpaid, local 
volunteers, who receive not much more than a brief training, to deliver medicines to outlying 
villages and schools, (Allen & Parker, 2011). One study in Uganda found that CMDs were so 
inadequately trained that they could not answer questions about the side-effects or long-term 
consequences of the medications they were distributing and that community members 
requested “experts” to better inform them (Rilkoff et al., 2013). With incomplete or 
inaccurate information, community members may be less likely to take medications that they 
think are unsafe.  
The Uganda study also found that incomplete courses of treatment were distributed to 
villages and that CMDs in seven out of eight communities were unsure which medications 




CMDs may unknowingly distribute medication in an ineffective or harmful way. 
Furthermore, some countries not only have undertrained CMDs, but the general attitude 
towards preventative medications is negative. Attempts at MDA have even erupted in violent 
protests and conspiracy theories about the medications making healthy children sick (Allen & 
Parker, 2011). 
In its current state, NTD management is ineffective and insufficient. Ultimately, this 
mismanagement feeds into the cycle of neglect and perpetuates poverty. At the diagnostic 
level, with no clear, focused definition of which diseases are considered neglected, resources 
are being spread too thinly. Research efforts, at both the prognosis and treatment levels, are 
underfunded and under-incentivized. Finally, the delivery method is full of complications 
and misinformation. Neglect exists at every level. The current management of NTDs itself is 
arguably a form of social and economic oppression that solidifies the cycle of neglect, 





SEX AND GENDER DIMENSIONS 
 
In their simplest definitions, sex is a biological determinant, and gender is a social 
construct (Vlassoff & Moreno, 2002). When it comes to health, social and biological factors 
can affect one’s risk for infection and one’s options for treatment. Sometimes, these factors 
overlap. For example, it may be unsafe for pregnant women to take a certain medication for 
biological reasons, but the fact that a safe alternative does not exist could be attributed to a 
social factor.   
Though gender biases and expectations vary greatly across cultures, their social 
burden cannot and should not be underestimated. Gender roles in a society can determine if a 
woman will receive higher education, inherit land, or be susceptible to violence (WHO 
Africa, 2012). It is important to note that the Administrative Committee on Coordination’s 
(ACC, 1998) definition of poverty includes all of these potential consequences. Ultimately, 
sex and gender can play an influential role in the way that women access healthcare, their 
vulnerability to diseases, and the impact of those diseases on their lives—physically and 
socially (Gazzinelli et al., 2012). 
Biological Factors 
Different diseases affect the body in different ways. As men and women have distinct 
biological structures and functions, it follows that the symptoms, severity, and treatment of 
diseases are going to vary between the sexes. Most obviously, these differences are seen in 
the reproductive system, primarily in regards to genitalia, menstruation, pregnancy and 




First, some neglected tropical diseases (NTDs) manifest their symptoms on the 
primary and secondary sex characteristics of females. For example, a symptom of lymphatic 
filariasis is lymphedema, or swelling caused by the buildup of fluid, which can affect the 
breast and vulva (Hotez, 2009). While this is a biological factor, social factors are also at 
play as some cultural practices only allow for the examination of women’s arms and legs, 
which may lead to an under-reporting of lymphatic filariasis and an underestimation of its 
disease burden on women (Hotez, 2009). 
Schistosomiasis is another NTD that can cause infection in the reproductive and 
urinary systems. About 93% of the global cases of schistosomiasis are localized in Sub-
Saharan Africa (SSA), particularly near bodies of water, as snails are the intermediate host of 
the parasitic worms that cause infection (Hotez & Kamath, 2009). The public health impact 
of schistosomiasis is second only to malaria in parasitic infections (Kjetland, Leutscher, & 
Ndhlovu, 2012) with an estimated annual DALY burden of 1.6 to 4.2 million in SSA (Hotez 
& Kamath, 2009). For women, lesions and infections commonly occur on the vagina, 
Fallopian tubes, and cervix, the latter of which is thought to be the main site of acquisition 
for HIV (Kjetland et al., 2012). Indeed, associations of co-infection between schistosomiasis 
and HIV have been found, and in the case of female genital schistosomiasis, the risk of HIV 
transmission is three-times as likely (Hotez, 2009). 
Menstruation creates a high demand of blood for a woman’s body, and the loss of too 
much blood can cause an iron deficiency and anemia. Essentially, anemia is a condition in 
which not enough oxygen is delivered to the body due to lack of red blood cells or a 
defective oxygen-binding protein in red blood cells called hemoglobin. While anemia can be 




cause intestinal bleeding (Hotez & Kamath, 2009). Therefore, hookworms create a 
compounding risk for the development of anemia in women, which can have disastrous 
effects. In fact, anemia is responsible for approximately 20% of maternal mortality and can 
result in low birth rate and infant mortality (Hotez, 2009). 
Hookworms directly impact the third biological factor: pregnancy. However, 
pregnant women have other unique burdens in the face of NTDs. Treatment of certain NTDs 
become difficult for women who are breastfeeding or currently pregnant because of the side-
effects from current medications. For example, the WHO has deemed Zithromax, used to 
treat trachoma, and Ivermectin, used to treat onchocerciasis and lymphatic filariasis, to be 
unsafe for pregnant women (Rilkoff et al., 2013). This complicates the typical delivery 
method for NTD preventive medications through MDA.  
Eradication of onchocerciasis in communities is possible if Ivermectin is distributed 
annually over a period of 10-15 years (Clemmons et al., 2009). Since MDA is the main effort 
to control onchocerciasis, women will often wait until the next year to receive treatment 
instead of seeking out individual treatment from health centers as soon as they are eligible 
again, which for Ivermectin is a month after the start of breastfeeding (Rilkoff et al., 2013). 
As one study in Sierra Leone found, only about 1.2% of breastfeeding women followed the 
recommended guideline for treatment after becoming eligible because of insufficient 
resources and information (Vlassoff & Moreno, 2002). Compounding these insufficiencies, 
women may spend up to 25% of their reproductive years pregnant and 60% of those years 
breastfeeding, indicating a large portion of their life without treatment (Rilkoff et al., 2013). 
Onchocerciasis is a long-term health issue for communities, which is made longer when 




While “biological oppression” is not explicitly included in the cycle of neglect, 
biology certainly impacts the vulnerability of women. NTDs’ comorbidity with other 
diseases and disorders, such as HIV and anemia, can certainly affect one’s productivity and, 
ultimately, economic status. The economic burden of seeking treatment becomes heavier 
with the increased burden of sickness. Furthermore, until pharmaceutical companies develop 
medications that are safe for pregnant and breastfeeding women, many individuals will be 
excluded from MDA and not necessarily by choice. Individuals do not have a choice in 
determining their sex, but that does not mean that they should not have a choice in accessing 
healthcare that is designed to limit risk of infections and increase safe, viable treatment 
options. 
Social Factors 
Social constructs of the way women should behave and interact with their 
environment also impact their health outcomes. Many factors contribute to gender roles. For 
women in SSA, family, community, and education are particularly defining, overarching 
many areas of life. Concerning health more specifically, traditional medical practices, 
stigmatization, and gender-based violence also play important roles. All of these factors have 
direct and clear implications for the cycle of neglect. By the same token, social oppression is 
more difficult to solve because it is a long-term issue built into the fabric of society. Unlike 
the biological factors, simply increasing resources and information will not break the cycle. 
These constructs solidified over time, and therefore they must be broken down incrementally. 
According to a WHO report on “Addressing the Challenge of Women’s Health in 
Africa (2012), women are the foundation for family and community life, but they may be 




Indeed, women play a crucial role in informally managing the health of their children and 
other household members, particularly in the areas of nutrition, sanitation, and 
immunizations.  However, immunizing children or rehydrating a child with diarrhea are time 
consuming and burdensome tasks, which can prevent women from seeking jobs outside of 
the house (Vlassoff & Moreno, 2002). Furthermore, women do not have to be the sole 
caretaker in a family. A study in Ghana found that when fathers took an active role in the 
immunization of children, more children were immunized in a time-efficient manner 
(Vlassoff & Moreno, 2002). While raising children and attending to a family is no doubt a 
noble and respectable cause, it can interfere with or even limit other opportunities, especially 
if women are expected to be the primary caregivers of a family. 
In the larger community, men are often in charge of the village meetings that make 
decisions about the control of diseases, while women are more often selected as the actual 
distributer and executer of these decisions (Clemmons et al., 2009). It is important to note 
that even though women are left out of the decision-making process, they largely agree with 
the men and do not voice dissatisfaction in their decisions (Clemmons et al., 2009). However, 
their lack of voice may extend into other areas of life. Women in rural parts of Kenya, 
Nigeria, and Sierra Leone are expected to labor in the fields in silence and without complaint 
despite health problems (Vlassoff & Moreno, 2002). Without a voice, women are left 
powerless and in subordinate positions. 
A hierarchy also exists within the healthcare system and workforce. Men often 
inhabit the highest ranked positions, such as doctors or journal editors, while women occupy 
subordinate positions, such as nurses and authors of journal articles (Vlassoff & Moreno, 




counterparts, even though they may have a more direct responsibility to the people in their 
care (Clemmons et al., 2009). Even in maternalistic cultures that highly value the role of 
women in society, customary inheritance laws still exist, which prevent women from 
inheriting land and, with it, gaining their independence (Vlassoff & Moreno, 2002). Once 
again, women are placed in a socially and economically subordinate position compared to 
men, increasing their higher risk for entering into the cycle of neglect. 
Even though these general gender roles exhibit some similarities to those of the 
developed world, the implications of these roles still affect women’s health and risk of 
poverty. Whether by choice or not, women are often left out of participating within their 
community, and women’s voicelessness in society is symbolic of their lack of power. Taken 
together, women are expected to be quietly complicit to the word of men; their authority 
within the community is undermined. Furthermore, with denied access to land rights, women 
rely on their male counterparts. Women may bear the brunt of the work in the field, but they 
cannot own the field. In all, these gender roles act as components of the ACC’s definition of 
poverty and are a violation of human dignity. 
 Women also lag behind men in opportunities for higher education—another 
qualifying component for ACC’s definition. For example, in Cameroon, the national literacy 
rate is close to 72%; among women it is only 52% (Fongwa, 2002). This finding is consistent 
across the continent. In a statistical report compiled by the World Health Organization 
Regional Office for Africa (WHO Africa, 2014), only nine out of 43 African nations 
surveyed had a higher literacy rate among women than men. In the same report, women 
consistently showed lower enrollment in all levels of education (WHO Africa, 2014). 




barriers of gender equality in education exist because of school fees, cultural favoritism 
towards boys, and inadequate or non-existent sanitation facilities for girls. 
         Education also plays a role in the way one communicates. With higher education, 
language becomes more sophisticated and grammatical. As a result, those who can 
manipulate language are perceived to be more powerful. In Nigeria, Cameroon, and 
Tanzania, a study by Clemmons et al. (2009) found that the language men and women use to 
describe their encounters with their diagnosis and treatment had larger implications for their 
autonomy. While men often used an active voice, women used a passive voice, indicating 
that men adhere and that women comply with medical advice. Further supporting this notion, 
a study in Uganda showed that men often asked CMDs difficult questions about the 
medications they were given, wanted to know more information, and were hesitant in taking 
the medications (Rilkoff et al., 2013). Women, on the other hand, accepted the medications 
and the programs distributing them more readily (Rilkoff et al., 2013). This poses potential 
risks for women, as an unquestioning compliance can make them vulnerable to 
misinformation or unsafe medications. Finally, language can be a reflection of one’s 
understanding and attempts at ownership. Men often try to name their disease, while women 
often describe their symptoms (Clemmons et al., 2009).  
Perhaps as a result of an education gap, women and men often seek treatment for their 
diseases from different sources. Women try to self-heal and utilize traditional medicine more 
often than men (Vlassoff & Moreno, 2002). In and of itself, this cultural practice may not 
have a bearing on the overall health of an individual. Multiple approaches to healthcare exist, 
and just as not all traditional methods are harmful, not all modern methods are beneficial 




of a microscope, quite literally. Individuals displaying certain symptoms and who test 
positive for specific pathogens are deemed diseased, while those who are asymptomatic and 
test negative are healthy. The definition of health is based on the biology of the individual. 
Physicians thus diagnose and treat accordingly. African cultures, on the other hand, view 
health through the lens of a telescope. Looking outward, individuals place themselves within 
a larger social context. One achieves true health by not only finding the balance between the 
mind and the body but also between the individual and the community (WHO Africa, 2012).  
As women are considered primary caregivers and the center of family life, it makes 
sense that they seek the advice of the community or cultural tradition, rather than seek an 
individualized diagnosis. Women often do not go to health centers for the diagnosis and 
treatment of many of their health problems, which contributes to underestimating the total 
burden and morbidity of a disease (Vlassoff & Moreno, 2002). As Peter Berger and Thomas 
Luckmann pointed out, health and illness are as much part of the physical reality of diseases 
as part of the socially and culturally constructed idea of them (Kleinman, 2010).  
For example, schistosomiasis from a biomedical perspective is a parasitic worm that 
can cause bloody urine or stool, enlargement of the liver, increased risk of bladder cancer, 
and in some cases neurological problems. However, the lack of health education and 
resources has resulted in an inaccurate view of the etiology and treatment course for this 
parasite, even among healthcare professionals (Allen & Parker, 2011). In some countries, 
these symptoms may be attributed to witchcraft and spiritual possession in which case 
biomedical intervention may be perceived to exacerbate the problem (Allen & Parker, 2011). 
Furthermore, some of these diseases also carry a social stigma, causing individuals to avoid 




the cost of being socially ostracized.  
Stigmatization and the exclusion of individuals is another social factor that feeds into 
the cycle of neglect and the definition of poverty. Onchocerciasis, which is a skin disease 
transmitted by blackflies that can also cause blindness or skin disease, exemplifies this 
process. Men and women perceive the impact of onchocerciasis differently (Vlassoff & 
Moreno, 2002). Women are often concerned about their appearance and opportunities in life 
with the visible skin disease, while men tend to focus on the sexual and reproductive 
implications of the disease (Vlassoff & Moreno, 2002). For women, this concern is not 
unmerited as onchocerciasis can cause disfigurement, threatening marriage prospects (Rilkoff 
et al., 2013). Hookworm and schistosomiasis infection can also cause infertility, which may 
carry a complex social stigma, especially in a society that values women as child-bearers 
(Hotez, 2009). Even if onchocerciasis, hookworm, or schistosomiasis do not cause immediate 
mortality, the social death from the disease’s stigma has far reaching consequences. Women 
may perceive the consequences and symptoms of the disease as worse than the disease itself, 
especially if it affects their appearance, marriage prospects, or child-rearing ability. 
 Women are particularly susceptible to violence, another component of the definition 
of poverty. While men are often victims of violence on the streets, women often experience 
violence in the home, causing long-term physical, psychological, and economic damage 
(Vlassoff & Moreno, 2002). Gender based violence often manifests in overt, physical terms, 
such as kicking, hitting, or rape. However, the social and economic oppression caused by 
gender roles is violence in itself. 
Structural violence is defined as causing harm to an individual or population via a 




systems (Farmer, Nizeye, Stulac, & Keshavjee, 2006). Within the framework of structural 
violence, the distribution of NTDs is not random but rather systematic, targeting those with 
little political voice, marginalized from society, and in an impoverished environment 
(Farmer, 2004). When women cannot participate in society, attend school, own land, and 
have a voice, violence is happening. Disease itself is violent. Blindness, disfigurement, and 
intestinal bleeding all become acts of violence perpetuated by society when the women of 
Africa carry a larger portion of global disease (WHO Africa, 2012). 
With poverty as the common factor, these diseases clearly discriminate against the 
marginalized, and women are particularly vulnerable to this discrimination. In the end, no 
matter how clever and wonderful medical treatments may be, if the social and economic 
determinants of these diseases are not understood and addressed, the medicine will fail 
(Farmer et al., 2006). In Sub-Saharan Africa, achieving health equality goes beyond just the 






PROPOSALS: BREAKING THE CYCLE OF NEGLECT 
 
The 2015 deadline for accomplishing the Millennium Development Goals (MDG) 
draws closer. Though substantial progress has been made in all 8 MDGs since their 
conception in 2002, these ambitious goals will still require attention far beyond 2015. As 
such, literature on neglected tropical diseases (NTDs) often cites that control of NTDs is not 
only a means to an end but also an end itself (Hotez, 2009). Clearly some of the MDG 
outlined in Table 2 will be directly impacted by NTD control, namely MDGs 1, 4, 5, and 6. 
However, through innovative approaches that particularly focus on women’s health, 
contributions towards achieving the other MDGs are possible.  
TABLE 2: Millennium Development Goals 
This table provides a brief description of the 8 MDG 
(United Nations, 2002). 
1. Eradicate extreme poverty and hunger 
2. Achieve universal primary education 
3. Promote gender equality and empower women 
4. Reduce child mortality 
5. Improve maternal health 
6. Combat HIV/AIDS, malaria, and “other diseases” 
7. Ensure environmental sustainability  
8. Global partnership for development 
 
It is important to note that these proposals are hardly exhaustive. Numerous other 
possibilities may exist. These “solutions” are simply recommendations that offer potential for 
breaking the cycle of neglect. Many of the following proposals are neither mutually exclusive 
nor unidirectionally benefit a single MDG. For example, through the control of NTDs, 




attend school and learn more, improving education. Child mortality will also decrease. 
Conversely, education is commonly regarded as a means of achieving gender equality and 
empowerment. Education can also reduce infection rates by increasing people’s 
understanding about how diseases spread. The Millennium Development Goals are vastly 
intertwined with their own objectives, the cycle of neglect, and the definition of poverty. As 
such, solutions should be just as integrated.  
Action plans should also address short and long term problems. Dr. Paul Farmer 
(2004), a physician-anthropologist and co-founder of Partners in Health, emphasizes the 
importance of pragmatic solidarity, which is not only identifying the needs of people and 
empathizing with them but also taking practical steps to fulfill those needs. Through a two-
pronged approach, pragmatic solidarity can be achieved by addressing the immediate medical 
concerns of NTDs and the larger issue of socioeconomic inequalities. Addressing the 
immediate medical need and the long-term socioeconomic need should not be viewed as 
competing approaches, but as complementary (Farmer et al., 2006).  
Instead of simply waiting for countries to develop in order to see a decline in NTDs, 
an active approach to NTD control can contribute to the development of countries by 
increasing socioeconomic growth and upholding MDGs (Allen & Parker, 2011). Co-
intervention will yield the best results of breaking the cycle of neglect. If NTDs cause 
poverty and that poverty causes NTDs, then no solution will work by focusing on either one 
separately. The dynamic between NTDs and poverty interconnect to such an extent with 
political voice, economic opportunities, and environmental hardships that they may best be 
understood as inseparable (Kleinman, 2010). Therefore, it is only appropriate for policies to 





 In the spirit of pragmatic solidarity, actions must be taken to immediately address the 
issue of disease. Essentially, access to healthcare is access to life. If the physiological needs 
of a person are not met, then social and political rights are weakened. The right to vote is 
meaningless if one is not alive to do so. Therefore, medical solutions are obviously essential 
to healthcare problems, especially for those who are suffering from disease right now. 
First, the conventional mass drug administration (MDA) method of delivery must be 
reconsidered. While MDA certainly reaches millions of people annually, others are still left 
out of the process. Indeed, for programs that treat lymphatic filariasis, 79% of the global, at-
risk population is left untreated (Ottesen, 2006). MDA is also complex. Mapping of the 
disease; logistical planning; advertising and raising social awareness; training community 
medical distributors (CMDs); acquiring, storing and administrating drugs; and measuring 
health outcomes and cost-effectiveness must all take place in order for MDA to occur in a 
community (Ottesen, 2006).  
If endemic countries invested more time and money in the training of CMDs, some of 
the attitudinal problems of MDAs could be resolved. Additional measures could be taken to 
ensure effective delivery methods, such as direct-observation therapy, which has been 
relatively successful in the administration of tuberculosis medications (Allen & Parker, 
2011).  With extra training, these volunteers could become paid employees of the 
government. This creates jobs in which the poor could conceivably work, improving the 
socioeconomic status of these individuals. Women, as caretakers for their families and 
healthcare distributors for their communities, would prosper in this job market.  




widely used drugs (WHO NTD, 2013). Therefore, strategies based on the individual may 
provide more targeted treatment, reducing the risk of drug-resistance and reaching 
populations, such as pregnant and breastfeeding women, that miss the annual drug 
distribution day. Door-to-door delivery of medications offers an effective way to target 
women who spend part of their day at home completing household chores, but may be 
ineffective for men who work outside of the house (Rilkoff et al., 2013). As a compromise, 
women in one village suggested that a centralized location replace the door-to-door model, 
which would allow community members to take a more active approach and seek 
preventative treatment themselves on their own time and under their own terms (Clemmons 
et al., 2009).  
MDA, door-to-door, and centralized locations all have their pros and cons. Clearly, a 
single approach is not going to work for every community. In the end, communities and 
individuals must have agency over this issue. It is imperative that communities have an 
active voice and are the ultimate decision makers in which approach works best for them. 
With a greater emphasis on communication, information sharing, and increased autonomy in 
the decision-making process for the way drugs are distributed, women move from 
compliance to adherence. While the former represents an authoritarian model built on 
silence, the latter emphasizes the important of partnerships in medicine. This ideological shift 
symbolizes the importance that partnerships have on women’s empowerment (Clemmons et 
al., 2009). 
Preventative medicine can achieve much, but other practical medical approaches are 
also needed. For example, water, sanitation and hygiene (WASH) are key factors in the 




infections, yet mass drug administration dominates the focus of current strategies (Freeman 
et al., 2013).  Without proper control and maintenance of water sources, reinfections will 
continue to occur, reliance on MDA will develop, and these diseases will begin to resist 
treatment by current medications. Ensuring water free of contaminants such as human feces 
or urine could reduce the rate of infection. In fact, through implementation of a WASH 
program, one village in Ghana completely eradicated three water-borne NTDs: 
schistosomiasis, yaws, and scabies (Fisher, 2006). 
Historically, WASH and NTD programs have failed to cooperate despite the fact that 
they could mutually benefit each other and they share a common target population: the poor 
and marginalized (Freeman et al., 2013). Social and economic developments form central 
components of both of these programs’ long-term goals. Furthermore, NTDs and WASH 
programs both take a human rights approach, as they have direct effects on the health of the 
individual and the community.  
Finally, women are particularly vulnerable to not only the burden of NTDs but also 
the burden of water access. As the primary caregivers of a household, women and girls in the 
developing world can spend up to 40 billion hours every year fetching water, often at the risk 
of their personal safety and at the cost of educational and vocational opportunities (Fisher, 
2006). Thus, women play a vital role in the development of these programs. With women’s 
participation in the planning, controlling, and educating stages, these programs are six to 
seven times more likely to succeed than programs without women’s participation (Fishcer, 
2006). The health of the community depends on recruiting women as an invaluable resource. 
 As some of these diseases are not transmitted directly through the water supply, 




al., 2012). However, water remains a life-source, not only for humans but also for many 
vectors that carry disease. Mosquitos cause dengue and lymphatic filariasis, water fleas cause 
dracunculiasis, and flies cause trachoma and onchocerciasis (Freeman et al., 2013). Though 
water sanitation might indirectly affect these vectors, a direct approach would be more 
effective. 
Without proper vector control, reinfection will continue to happen (WHO NTD, 
2013). Despite this, in 2008, R&D on vector-control for kinetoplastics, pathogens that cause 
human African typanosomiasis, visceral leishmaniasis, and Chagas disease, received no 
reported funding (Moran, 2011). Typical vector control relies on pesticides, corresponding 
largely with the agricultural sector (WHO NTD, 2013). In the case of lymphatic filariasis, 
these pesticide treatments have also proven expensive and ineffective (Ottesen, 2006). 
Communication satellites have also been used as a more high-tech solution by tracing the 
flies that cause onchocerciasis in order to kill their larvae (Wood, 2008). While the latter 
approach is more targeted and therefore more likely to be effective, the expense poses 
difficulties for much of the developing world. 
Pesticides may largely eliminate vectors in the field, but women face additional risks 
in the home. Women raising children are three to four times more likely than men to develop 
trachoma, and the burden of domestic chores, such as collecting water, places women at high 
risk for contracting dracunculiasis (WHO NTD, 2013). However, bed nets, polystyrene 
beads, and residual spraying in the home reportedly have tremendous value in reducing 
transmission of lymphatic filariasis and the overall density of the mosquito population 
(Ottesen, 2006). As primary caretakers, women are in a position to play a direct role in vector 




their personal funds to purchase bed nets for the entire family (Clemmons et al., 2009). 
However, current strategies at marketing specifically to these gender differences to promote 
the use of bed nets are insufficient (Vlassoff & Moreno, 2002). Encouraging women to use 
bed nets in their house and increasing their understanding of the transmission of diseases may 
position them to move vector-borne neglected tropical diseases from elimination to 
eradication. 
 Finally, the overall healthcare infrastructure must improve in order to effectively 
control NTDs. Sub-Saharan Africa carries 24% of the global burden of disease, but it only 
has 10% of the population, 3% of the medical personal, and 1% of the economy (Kaschula, 
2013). Obviously, a vast health disparity exists between SSA and the rest of the world. While 
nothing will quite replace the “simple” solution of training more local physicians and 
increasing the number of available hospitals and clinics, other options may offer more 
immediate relief. 
Technological support through increasing satellite power could provide real-time 
communication between doctors and field workers in the diagnosis, treatment, and 
prevention of diseases. As the cost of bandwidth for Internet access is 10-100 times more 
expensive in Sub-Saharan Africa than in the US or most of Europe, the cost would have to be 
reduced (IDRC, 2004). Many African countries have limited budgets, lack of infrastructure, 
and inhibiting policies, which make increasing satellite power difficult (IDRC, 2004; Wood, 
2008). However, start-up companies and non-profit organizations are beginning to see the 
potential of increasing Internet connections. The New York Times reported that Google has 
sponsored the installation of a solar-powered satellite dish in rural Africa, which has reduced 





Telecommunication can improve economies (IDRC, 2004) and increase food 
security, both of which are important in supporting the poor and controlling NTDs, through 
crop evaluations (Wood, 2008). In Nigeria, for instance, employment increased as a direct 
result of embracing policy reform to accommodate satellite use (IDRC, 2004). By expanding 
satellite use, doctors and health professionals in the developing world could communicate in 
real-time with doctors in the developed world who have readily available resources (Wood, 
2008). This type of support cannot be underestimated. “Brain drain” can lead otherwise 
qualified individuals to leave under-resourced and under-supported jobs for more well-
paying positions in other countries. In the case of pathology, for instance, consultations via 
satellites may provide the necessary support and encouragement for pathologists to stay in 
under-resourced areas (Kaschula, 2013). Internet access also brings information, news, and 
journal articles, allowing medical professionals to remain up-to-date with current practice 
(Kaschula, 2013). Ultimately, telemedicine brings expertise where expertise is lacking. 
 In summary, women can play a vital role in reforming mass drug administration, 
strengthening water, sanitation, and hygiene programs, and reducing vector-borne diseases in 
the home. Increasing satellite power and telemedicine also present promising solutions for 
controlling neglected tropical diseases. While these proposals focus on reducing poverty and 
combatting diseases, MDG 1 and MDG 6 respectively, they most directly affect MDG 6, 
specifically targeting the “other” diseases.  
By combatting diseases, maternal health (MDG 5) is improved. The reduction of 
hookworm infections through partnerships with water, sanitation, and hygiene programs 




household chores that unequally burden women would pose less health risks for them and the 
rest of their household. Vector control within the house would also reduce the rate of 
infection among the household, reducing child mortality (MDG 4). In addition, child 
mortality is further reduced when women share the burden of child immunization with men 
and have more choices aside from MDA. Finally, access to clean water fulfills MDG 7, 
ensuring environmental sustainability. Solar powered satellites that improve farming 
techniques and reduce the demand on valuable resources also alleviates the pressure on the 
environment. 
 In relation to eradicating extreme poverty (MDG 1), medical interventional addresses 
many of the factors mentioned in the ACC’s definition of poverty. Specifically, by increasing 
medical resources, individuals have greater access to clinics and healthcare. While satellite 
technology may not increase women’s land rights, it can improve the ability to grow crops, 
save money by reducing travel expenses, and ultimately increase their power to feed their 
family. Together, these increase the security of women, their households, and their 
communities. 
Politically 
Political will and commitment are prerequisites for the success of any widespread 
initiative or program (WHO Africa, 2012). Government involvement can provide investment, 
sustainability, and at the very least, a symbolic blessing for a program. However, in order for 
policies to succeed in reducing poverty, impact analyses must examine the way these policies 
affect both men and women (ACC, 1998). Without a gender analysis, the health gap between 
men and women may continue to widen. The ACC states that the poor must take active roles 




As women stand as a population particularly vulnerable for poverty, this statement must be 
understood to include women. 
Political action should first be developed in countries where these diseases are 
endemic. To emphasize the importance of taking preventive treatments against NTDs, some 
have suggested a requirement via local legislation (Allen & Parker, 2011). Cultural 
interpretation of medicine and disease may hinder treatments, but legislation is symbolic of 
local governments’ investment and commitment to address NTDs. Theoretically, citizens will 
participate in taking preventive drugs to not only follow the law but also because the 
government essentially deemed these drugs as harmless and beneficial. Laws would have to 
be carefully crafted to ensure that the intent of the policy is actually being achieved and that 
laws do not cause unintentional harm. For instance, if a policy induced a fine or stated that a 
child could not go to school without receiving preventive treatments, then impoverished 
populations might be further oppressed.  
Health policies must specifically address gender equality with reference to the status 
of women and their access to healthcare in order to reduce the gender gap and improve 
efficiencies of health resources (Gazzinelli et al., 2012). As previously discussed, women 
differ from men in their expectations of and interactions with the healthcare system. As 
society often defines their roles differently, it follows that health policies should also target 
these populations separately. In terms of health, equality does not necessarily mean “the 
same.” In order to have equal outcomes, the inputs may be different (Vlassoff & Moreno, 
2002). For example, since women are at higher risk for anemia when infected by hookworms 
or schistosomiasis, they may require additional supplements in order to achieve the same 




not meant to exclusively favor women but rather bridge the gender gap and promote equality 
across health outcomes. 
Despite this, women remain consistently underrepresented in the political process 
across Africa. Due to social stereotyping and gender discrimination that leaves girls 
uneducated and at home, women represent less than 10% of the parliament in most countries 
(WHO Africa, 2012). In order for women’s issues to be on the agenda, women need to be 
represented. Increased political involvement allows women to participate more effectively in 
society by giving them a voice and therefore power—directly reducing some of the 
components of poverty and meeting MDG 3. 
Government spending on healthcare across Africa is also dismal. Each year African 
governments continually spend a smaller portion of their budget on healthcare expenditures 
than the rest of the world (WHO Africa, 2014). In 2008, only 21 countries in the African 
Region were spending the recommended US$44 per capita on health (WHO Africa, 2012). 
Even though the African Union agreed in 2001 to raise their government health expenditure 
to 15%, only six out of 47 countries met this goal ten years later (WHO Africa, 2014). As 
mass drug administration and similar programs are largely planned, coordinated, and 
financed by the national governments, these sorts of programs cannot succeed without proper 
funding. 
Out of pocket (OOP) payment for healthcare, the most common form of healthcare 
expenditure in the African Region, poses huge obstacles for low-income countries (WHO 
Africa, 2012). Both men and women may wait until their disease has progressed to a 
devastating stage before seeking treatment. Once again, women are particularly vulnerable. 




children utilize healthcare services more when OOP is reduced (WHO Africa, 2012). This 
indicates that the desire to seek medical attention is prevalent, but the economic burden 
stands as a huge barrier for women’s access to healthcare. Furthermore, by phasing out OOP 
payment, women have more money to invest in necessities for their household and family, 
such as sanitation facilities, nutrition, and education (WHO Africa, 2012). 
 Rwanda exemplifies the power of pro-poor, pro-women policies in government. 
Rwanda not only spends the highest percentage—at 23.8%—of its total government budget 
on healthcare compared to all other African countries, but its parliament contains more 
women than men—at 56% (WHO Africa, 2014). The Ministry of Health and the Ministry of 
Gender and Family Promotion are both under the direction of women ministers. As a woman 
and public servant, Dr. Agnes Binagwaho (2012), Rwanda’s Minister of Health, specifically 
mentions gender and health policies in her mission statement as a mechanism for political 
strength and engagement. Rwanda has also largely eliminated their OOP fees in favor of 
community insurance schemes that share the burden of payment, which has allowed coverage 
for about 90% of the population (WHO Africa, 2012). These community-based insurance 
schemes have led to remarkable improvement in the health and lives of Rwandans. While not 
all countries may benefit from the same policies, the outcomes in Rwanda symbolize to the 
rest of Sub-Saharan Africa—and the entire world—the critical role that women can play in 
governance. 
Economically 
Economic solutions must address and financially respond to both neglected tropical 
diseases and poverty. First, research on NTDs is poorly resourced and underfunded. Only 




world’s population (Hunt, 2007). In effect, research and development (R&D) itself is in a 
state of impoverishment. Thus, incentives must be provided to help spur research in the areas 
of prevention, diagnostics, prognostics, treatment, and delivery. In addition to research on 
NTDs specifically, research is also needed in women’s health and gender’s role in medicine. 
Second, as NTDs are both a cause and consequence of economic oppression, economic 
empowerment of women is essential for NTD eradication.  
According to Drugs for Neglected Diseases Initiative and Médecins Sans Frontières 
(2012), three fundamental problems exist in the development of medical innovation today. 
First, in today’s market driven economy, commercial potential takes precedence over global 
need. Second, as innovative medicines are designed for resource-rich settings, developing 
countries become a mere afterthought. Finally, innovation remains expensive and is often 
priced too high for poor patients to reasonably access its products. In summary, current NTD 
treatments can be costly, unsafe, long-term, and complex (Mackey & Liang, 2012). 
Pharmaceutical companies have little incentive to create or to produce drugs for NTDs 
because their target population cannot afford costly treatment plans. Meanwhile, the target 
population is trapped in poverty because they are not being treated for the diseases that are 
crippling them. 
 As such, research on NTDs must be separated from the market-driven model and 
adopt a “health needs” model (MSF, 2012). Tax credits, subsidies, and grants could provide 
motivation to the private-sector to increase R&D for NTDs (Hunt, 2007). Tax credits could 
be given to companies that focus on the highest priority, global health needs, while reducing 
the tax credits already given to companies that focus on low priority lifestyle drugs, as 




These incentive programs should encourage and reward pharmaceutical companies that 
market drugs at an affordable rate according to the national budget of countries where these 
diseases are endemic (Pérez-Casas et al., 2001). For example, prize schemes could also be 
created to reward researchers that produce a product under a certain price (MSF, 2012). This 
would create a competitive atmosphere that would allow for only the best ideas to flourish 
without creating products that are too expensive or too high-tech for developing countries. 
From there, pharmaceutical companies could expand their donations to include 
expired drugs that would otherwise be destroyed or too expensive to donate. The expiration 
date on many drugs is arbitrary and does not reflect the actual amount of time it takes to lose 
their potency (Coffey, 2012). To be clear, this does not mean that developing countries 
should become a dumping ground for all expired medications. Rather, emphasis on 
prolonged potency testing of relevant drugs would ensure maximum use in resource-poor 
countries (Coffey, 2012).  Aid should never be a burden upon the beneficiary, whether in cost 
or donation. As with many of these solutions, review processes would have to be developed 
and established to ensure unintended consequences are not hurting those that they are trying 
to help. Furthermore, the ethical ramifications of donating expired drugs would have to be 
explored. 
Other economic incentives could be explored in relation to the method used in trading 
these medications. Tariffs on imported medicines and vaccines for NTD products, which 
currently range from 2% to 15% in about half of Sub-Saharan African countries, could be 
reduced or eliminated (Mackey & Liang, 2012). Trade and delivery become just as important 
as research and development because drugs are only good if they are accessible to the 




for NTDs, global partnerships (MDG 8) are formed, specifically through the sub-goals of 
increasing distribution of essential medications, providing access to scientific advancement 
from the private sector, and decreasing tariffs and barriers to trade. In an increasingly 
globalized world, isolation is truly a sign of poverty, so MDG 8 is crucial to removing social 
and economic oppression. 
 While research is needed on NTDs, research is also needed specifically on women’s 
health. Dr. Luis Sambo, the Regional Director for Africa, stated in a “Report of the 
Commission on Women’s Health in the Africa Region” that quality scientific research on 
women’s health in the African Region is lacking (WHO Africa, 2012). In relation to NTDs, 
typical studies have focused on gender issues associated with schistosomiasis and 
onchocerciasis but have ignored other NTDs such as human helminthiasis (Gazzinelli et al., 
2012). Furthermore, a need exists for applied research, translating gender-issues into health 
policies for gender-equality (Gazzinelli et al., 2012). With a greater understanding of 
women’s health, NTDs can be better targeted and treated. 
 Though economic resources need to be directed to the research of NTDs and 
women’s health, economic resources can also directly benefit women by means of 
microloans and credit access. Currently, women in Sub-Saharan Africa have limited access to 
credit, and as a result, they cannot effectively participate in the market place (WHO Africa, 
2012). However, micro-credit allows for women and the poor to play an active role in 
poverty eradication by taking initiative in innovation and entrepreneurship (ACC, 1998). Dr. 
Agnes Binagwaho (2012) explains in her mission statement the way communities in Rwanda 
have found ways to invest in themselves. Members of the community pool their money in a 




paying it back to the cooperative. It is this sort of innovative, community-based thinking that 
will allow for the economic development of communities and women. While methods that 
are effective in Rwanda may not be effective in the rest of Sub-Saharan Africa, community-
led solutions offer the most promising approach. 
 Finally, women could stand to benefit economically through the granting of land 
rights. Though women in Sub-Saharan Africa complete about 70% of the labor on agriculture 
land, they only own 1% of that land (WHO Africa, 2012). The right to own land empowers 
women, fulfilling MDG 3, but also combats one of the components of poverty by granting 
women access to their own land to grow food to feed their family. Credit access and land 
ownership can also increase women’s effective participation in society by raising their status 
within their home and community (WHO Africa, 2012). Women move from their 
subordinate position to positions of value and authority. Clearly, by investing in research and 
the economic empowerment of women, a nation moves one step closer to eradicating 
extreme poverty (MDG 1). Economic support results not only in economic freedom but also 
in social freedom. 
Socially 
Perhaps one of the most important resources available for the development of Africa 
is the human resource. As women make up roughly 50% of the population, it stands to reason 
that investment in the empowerment of women is a cost-effective measure, providing a 
positive feedback loop in health and economic development (WHO Africa, 2012). In fact, 
women are the “key agents of change” when it comes to community health and the control of 
NTDs, playing an important role in social influence, vector control, and community 




Therefore, successful interventions in the control and eradication of NTDs will 
include a comprehensive plan to empower women. All the solutions presented above 
contribute to the social development of women. In some way, whether directly or indirectly, 
they empower women to be more independent and vocal about the issues that affect them. 
Water access empowers  (Fisher, 2006). Gender policies empower (Binagwaho, 2012). 
Micro-credit empowers (ACC, 1998).  
Education stands as perhaps the most significant component of empowerment and 
ultimately leads to the improvement of health and socioeconomic status. In fact, the ACC 
(1998) specifically pointed out that education and women’s empowerment are critical to the 
eradication of poverty. It has even been suggested that education and women’s empowerment 
are invaluable to the overall health of a country (Fongwa, 2002). Ultimately, as women 
increase their social status, they become assets to their community, and their vulnerability—
both for poverty and NTDs—drastically decreases. Access to schools and increased 
education directly fulfills MDG 2.  
Empowering women allows them to break out of traditional gender roles and 
participate more fully in their community, country, and culture. Traditionally, women make 
up the majority of the health sector, but they largely fill subordinate and supporting roles, 
such as nurses and midwives (WHO Africa, 2012). Despite this, nurses play a vital role in 
rural health centers, where NTDs are prevalent and nurses are the only available health 
resource (Fongwa, 2002). In order to increase the number of women physicians, education 
must become as much of a priority for girls as it is for boys in primary and secondary 
schools. Though this requires a long-term investment, the returns are invaluable, as women 




physician than from a male physician (WHO Africa, 2012).  
While research and development for the biological elements of NTDs are essential, 
the social causes cannot be underestimated because the conditions of poverty allow these 
diseases to develop. Even though the US is geographically not tropical, economically 
developed, and medically advanced, NTDs are still found amongst the poorest populations in 
America. Empowered female physicians and women in general could therefore provide better 
insight into the specific factors that trap their community in poverty and that place the 
populace at risk for disease. 
As previously stated, health in Sub-Saharan Africa is best understood from the 
community perspective. Up to 80% of individuals in SSA seek treatment from traditional 
healers before western medicine, due to not only the lack of access to hospitals but also due 
to increased spiritual and familial support (Kaschula, 2013). From an anthropological 
perspective, this is important knowledge, as cultural competence contributes to NTD and 
poverty reduction.  
Traditionally, physicians and health professionals do not target, diagnose, or treat the 
larger pathology of structural violence or similar social interventions (Farmer et al., 2006). 
However, as a symptom of structural violence, a prescription for clean water, credit access, 
or education may be the best medicine for NTDs. This emphasizes the need for physicians 
working with poor populations to understand the social structure of their society in order to 
increase empathy with their patients. Women in the community have a natural instinct for 
this. The social empowerment of women brings cultural competence and a much needed 
voice to the strategies used to provide healthcare to a community. 




actions taken medically, politically, economically, and socially. Table 3 provides a summary 
of the proposed solutions and the Millennium Development Goals that they fulfill. Women 
stand at the center of the cycle of neglect and therefore at the center of the solution. 
 
Medically MDG 6: Combat "other 
diseases" 
Restructuring of MDA 
Telemedicine 
MDG 4: Reduce child mortality Vector-control 
MDG 5: Improve maternal 
health 
Water, sanitation and hygiene 
programs 
MDG 7: Ensure environment 
sustainability 
Solar-powered satellites 
Politically MDG 3: Promote gender 
equality 
Policies for gender equity 
Policies for treatment and/or 
prevention 
Women in parliament 
Replace OOP payments 
Economically MDG 1: Eradicate poverty Credit access 
Grant land rights 
MDG 8: Global partnerships Encourage trade and donations 
by reducing tariffs 
Incentivize private-sector for 
R&D 
Socially MDG 3: Empower women Education 
Medical, political, economic 
empowerment 
MDG 2: Education Access to schools 
Increase female physicians 
Cultural competence of doctors 
TABLE 3: Breaking the Cycle of Neglect 
This table provides a list of proposals as presented in the text and their relation to the 







Poverty, human rights, and neglected tropical diseases are intricately intertwined. 
Thus, eradication of NTDs and global poverty are complex problems that will not be solved 
with any one approach. Poverty is more than just not earning a certain amount of money. It is 
more a state of constant social and economic oppression, where lack of adequate food, water, 
healthcare, and education prevents people from self-actualizing and reaching their full 
potential. It is a symptom of a larger pathology, namely structural violence. A comprehensive 
policy is not about making everyone the same but rather working together for a world in 
which every person can achieve a level of life that is right for them.  
If income distribution is viewed as a standard bell curve, albeit skewed, then someone 
is always going to fall above and below the average. It is not about trying to defy the laws of 
mathematics and redefine the meaning of average. Someone will always be poorer than 
someone else, but the goal is to eliminate the symptoms of poverty, such as the lack of social 
capital, education, or healthcare. Progress towards the elimination of NTDs acts as a 
“powerful equalizer,” bridging gaps in social and economic disparity (WHO NTD, 2013). By 
viewing neglected tropical diseases through the lens of human rights, the movement is 
advanced towards equal dignity and respect for every person—rich or poor. 
In regards to a comprehensive policy or strategy that addresses NTDs and women’s 
rights from a medical, political, economic, and social standpoint, opponents may question the 
cost-effectiveness. However, healthcare and empowerment are not commodities, they are 




then society is guilty of normalizing the death of that person. Furthermore, in this light, when 
the rights of an individual are violated, as is the case when women or the poor bear an 
uneven burden of disease, then the rights of everyone are violated.   
Humans are not just connected by their rights and their dignity; they are also 
connected by their biology. Dr. Nathan Wolfe, an epidemiologist, said in a public lecture at 
Angelo State University that airplane flight patterns are a mixing vessel of microbes on the 
planet: bacteria in the Amazon can be transported to Southeast Asia and viruses in Africa are 
not so far from North America anymore. Pathogens do not respect national boundaries. In a 
globalized world, society is only as healthy as its vulnerable populations. Furthermore, if 
improper use of pesticides or medications causes mutations in any of these pathogens, then 
NTDs may not be solely a problem of the poor. 
Humanitarianism has a long history of trying to help but really causing more 
disruption. The sociologist Robert Merton proposed the theory that directive action often has 
unintended consequences, whether predictable or unforeseen, good or bad (Kleinman, 2010). 
Medical aid is especially at risk because the concept of health, the understanding of illness, 
and the rationale of taking medications differ substantially across cultures. As with any 
humanitarian mission, the obstacle remains of ensuring that aid is delivered to the people 
who are in need of them and not to the hands of corrupt governments or insurgents. 
While this thesis is largely built upon generalities pertaining to Sub-Saharan Africa, it 
is important to note that success and sustainability ultimately depend upon on-the-ground 
partnerships (Allen & Parker, 2011). Community partnerships prevent blanket approaches to 
solving issues like public health and poverty by encouraging individuality and specificity to 




against disruptive humanitarianism. Each community will be unique and may require slightly 
different solutions for the same problem. Grassroots efforts cannot be underestimated. 
Whereas large international agencies can miss the nuances of a community, grassroots 
organizations are deeply aware of the specific concerns of a community. After all, the 
countries where these diseases are endemic will be in the best position to solve their own 
problems, not an outside agency (Farmer, 2004). 
As Her Excellency Mrs. Ellen Johnson Sirleaf, the President of the Republic of 
Liberia, stated so eloquently, “a nation thrives when mothers survive; we must strive to keep 
them alive” (WHO Africa, 2012). Feminism may be thought to be mainly a Western idea; 
however, developing countries are playing key roles in international politics by promoting 
gender-sensitive policies for the health of men and women (Vlassoff & Moreno, 2002). In 
fact, all 46 countries in the African Region are signatories to the United Nations Convention 
on the Elimination of All Forms of Discrimination Against Women, which includes 
provisions for women’s health (WHO Africa, 2012).  
The next step is to move this political will to political commitment and action. 
Women stand at the center of it all, acting as a valuable yet untapped resource in Sub-
Saharan Africa. In essence, the cycle of neglect can be shattered from the inside out through 
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